DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Phendimetrazine (Phendimetrazine Tartrate) - Summary

 
 



SUMMARY

PHENDIMETRAZINE TARTRATE TABLETS, USP 35 mg 

Phendimetrazine tartrate, as the dextro isomer, has the chemical name of (2S,3S)-3,4-dimethyl-2-phenylmorpholine L-(+)-tartrate (1:1).

Phendimetrazine tartrate is indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m2 or higher who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone.

Phendimetrazine tartrate is indicated for use as monotherapy only.


See all Phendimetrazine indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Phendimetrazine

FDA Panel Endorses Liraglutide as Obesity Treatment
Source: Medscape Diabetes & Endocrinology Headlines [2014.09.12]
An FDA committee voted 14 to 1 in favor of liraglutide as an obesity treatment, stipulating that lingering safety questions be addressed in postmarketing studies.
Medscape Medical News

FDA Approves New Obesity Drug
Source: MedicineNet Obesity (Weight Loss) Specialty [2014.09.12]
Title: FDA Approves New Obesity Drug
Category: Health News
Created: 9/11/2014 12:36:00 PM
Last Editorial Review: 9/12/2014 12:00:00 AM

Third Obesity Drug Wins FDA Okay
Source: MedPage Today Cardiovascular [2014.09.11]
(MedPage Today) -- Following an earlier snub, the FDA finally approved the weight-loss drug Contrave, a combination of bupropion and naltrexone, the agency announced.

FDA Approves Bupropion/Naltrexone (Contrave) for Obesity
Source: Medscape Diabetes & Endocrinology Headlines [2014.09.10]
After a rocky start, the FDA has finally approved the obesity medication, but with a boxed warning about the risk for suicidal thoughts and serious neuropsychiatric events.
FDA Approvals

'Fingerprinting' cell metabolism points toward study of obesity, diabetes
Source: Cholesterol News From Medical News Today [2014.09.10]
Researchers have shown how to use a new imaging platform to map lipid metabolism in living cells, discovering specifically where cholesterol is stored and pointing toward further studies in...

more news >>


PATIENT REVIEWS / RATINGS / COMMENTS

Based on a total of 1 ratings/reviews, Phendimetrazine has an overall score of 10. The effectiveness score is 10 and the side effect score is 4. The scores are on ten point scale: 10 - best, 1 - worst.
 

Phendimetrazine review by 27 year old male patient

  Rating
Overall rating:  
Effectiveness:   Highly Effective
Side effects:   Severe Side Effects
  
Treatment Info
Condition / reason:   weight loss
Dosage & duration:   35mg taken 2 times per day for the period of 4 weeks
Other conditions:   none
Other drugs taken:   none
  
Reported Results
Benefits:   A total of 20 pounds lost in one month.
Side effects:   Although I reached my goal weight, the drug made me very restless, anxious, moody. I also experienced headaches, and falling asleep was not easy while on this drug. Dizziness, light headed.
Comments:   Take one 35mg pill in the morning and one after lunch to curb appetite. I fond myself able to stay more active and run longer at the gym. It's a toss up if the results were worth the side effects. It's obvious that a drug this strong that makes you want to run a marathon and not eat can't be good for you!

See all Phendimetrazine reviews / ratings >>

Page last updated: 2014-09-12

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014